Free Trial

More results...

Filter by Content types
Regulatory data
Regulatory reports
Market reports
News analysis

Alerts LATEST ALERTS

  • Europe European Council adopts regulation to reduce and recycle packaging ...
  • Lithuania Reminder of tobacco display ban in convenience stores from 1st January ...
  • Indonesia Minimum retail price for tobacco and nic products set to increase ...
  • Sweden Snus product recalled due to exceeding permitted chemical limit ...
  • Vietnam National Assembly issues resolution formally requesting HTP ban ...
  • District of Columbia - United States Swedish Match to pay over $1m to resolve Zyn sale violation ...
  • Lithuania Parliament approves sanctions amendment for under-age sales ...
  • Japan Government plans to raise HTP excise duty ...
  • New Zealand Smokefree Environments Bill adopted in final reading ...
  • Russia Bill aims to ban sales of tobacco and nic products near universities ...
  • Belarus Bill to increase tax on tobacco and nic-containing products adopted ...
  • Spain Last day of consultation on nic pouches and herbal heated product rules ...
View all
News analysis

PMI allowed to make modified risk claims in US for Iqos 3 but import ban stands

Written by || 15th March 2022 || News analysis | Iqos | GeographiesNorth America United States

The US Food and Drug Administration (FDA) is allowing Philip Morris International (PMI) to market its Iqos 3 heated tobacco device with some reduced risk claims. The decision does not override the current ban by the International Trade Commission (ITC) on Iqos sales and imports but opens the door for the company to cite the authorisation in future marketing.

Read full article

Download the full news analysis

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

I'm already a subscriber
Author default picture

TobaccoIntelligence

This article was written by one of TobaccoIntelligence’s international correspondents. We currently employ more than 40 reporters around the world to cover individual nicotine markets.

Our Key Benefits

The global novel nicotine market is in an opaque regulatory environment that requires professionals to be on top of industry developments to make informed decisions and optimise their strategy.

TobaccoIntelligence provides organisations with leading market and regulatory data analysis to anticipate and understand market developments globally and the impact of regulatory changes to the business.

  • Stay informed of any legal and market change in the sector that impacts your organisation
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organisation

Thanks for getting in touch with us

Please leave your enquiry and we will get back to you within 24 hours

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.

Sign up to our newsletter

Stay up-to-date with key market trends and regulatory news and receive complimentary data on a regular basis.

"*" indicates required fields

Name*
*
This field is for validation purposes and should be left unchanged.